The company entered the OTC business in 2007 and it has grown to have established brands such as Manforce, HealthOK, Prega ...

Bidders for Sanofi’s consumer healthcare unit are revising their offers in part to address concerns around potential ...

As Sanofi continues to clean out its medicine chest, Italy’s Recordati is getting in on the action. | Recordati is floating ...

Three years later, health and beauty brand L’Oreal acquired a majority ... but the company also develops over-the-counter medication as well. Sanofi now covers seven major therapeutic areas ...

Italian pharma group Recordati said on Friday it would buy from Sanofi the global rights to a drug used to treat cold ...

Sanofi and Regeneron’s blockbuster drug Dupixent successfully treated patients with chronic spontaneous urticaria, an inflammatory skin disease, in a late-stage trial, the companies announced on ...

Sanofi SA (NASDAQ:SNY) announced its plans to spin off its consumer healthcare business as the French pharmaceutical company ...

Sanofi’s consumer health division sells over-the-counter medicines like the allergy ... “New leadership, new focus, ...

The blockbuster Sanofi and Regeneron Pharmaceuticals drug Dupixent, already commercialized in several skin and lung disorders, has expanded its FDA-approval to chronic obstructive pulmonary ...

GSK , Sanofi and CSL Ltd have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, a ...

(Bloomberg) -- Sanofi has received binding offers for its consumer health ... previously bought a controlling stake in ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...